Saturn V Capital Management LLC has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $198 Billion distributed in 21 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Ascendis Pharma A/S with a value of $31.1B, Disc Medicine Inc with a value of $25.7B, Cg Oncology Inc with a value of $14.1B, Xenon Pharmaceuticals Inc. with a value of $13.9B, and Merus N.V. with a value of $13.6B.

Examining the 13F form we can see an decrease of $57.2B in the current position value, from $255B to 198B.

Saturn V Capital Management LLC is based out at Austin, TX

Below you can find more details about Saturn V Capital Management LLC portfolio as well as his latest detailed transactions.

Portfolio value $198 Billion
Healthcare: $149 Billion

Stock Holdings Table Companies Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 21
  • Current Value $198 Billion
  • Prior Value $255 Billion
  • Filing
  • Period Q1 2025
  • Filing Date May 15, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 1 stocks
  • Additional Purchases 11 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 9 stocks
Track This Portfolio

Track Saturn V Capital Management LLC Portfolio

Follow Saturn V Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Saturn V Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Saturn V Capital Management LLC with notifications on news.